TRVN trevena.com: Rasio nilai perusahaan marang pendapatan

Simbol resmi perusahaan Trevena (TRVN)

Challenges in bringing new analgesics to market are putting pressure on the business of Trevena, Inc. (TRVN). Bankruptcy risks and the slow rollout of Olinvyk are complicating the company's financial position. The EV/Sales multiple reflects capitalization dynamics relative to revenue, with the current metric standing at . Simultaneously, Trevena, Inc. (TRVN) is implementing ESG standards by transitioning to eco-friendly packaging and closed-loop water systems at its plants.

Nilai perusahaan marang pendapatan Trevena, Inc. (TRVN): kanggo periode 04.07.2022 - 20.11.2026

TRVN (Trevena, Inc): rincian analitis lan laporan miturut indikator

- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
Pambiji fundamental:trevena.com - TRVN
Produk sing diprodhuksi Trevena Inc.

To isolate the fundamental stability of Trevena, Inc. (TRVN) from market noise, it is necessary to compare the total enterprise value with sales volume, excluding the impact of debt. By analyzing the EV/Sales ratio on the GURU.Markets platform, an investor assesses the efficiency of revenue capitalization, which Trevena, Inc. (TRVN) optimizes through the implementation of automated clinical data processing systems to enhance research accuracy.

Analisis pesaing

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan SCLX (Scilex Holding Company, Inc.)|Rasio nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Rasio nilai perusahaan marang pendapatan Alpha Cognition ACOG|CGTX - Nilai perusahaan marang pendapatan|IKT - Rasio nilai perusahaan marang pendapatan|SAVA: Rasio nilai perusahaan marang pendapatan|Assertio Therapeutics (ASRT) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Coya Therapeutics Inc (COYA)|Rasio nilai perusahaan marang pendapatan Vistagen|Rasio nilai perusahaan marang pendapatan OVID (ovidrx.com)|Rasio nilai perusahaan marang pendapatan Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Multiplikator nilai perusahaan marang pendapatan|Alterity Therapeutics Ltd. - Nilai perusahaan marang pendapatan|CLNN - Nilai perusahaan marang pendapatan|PEPG - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Rasio nilai perusahaan marang pendapatan|ANVS (Annovis Bio, Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan gracetx.com|Multiplikator EV/Sales Firefly Neuroscience, Inc.|Rasio nilai perusahaan marang pendapatan ANEW Medical (KLTO)|NRSN - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales RVPH (Reviva Pharmaceuticals Holdings Inc.)|Koefisien nilai perusahaan marang pendapatan MTVA (metaviatx.com)|NeurAxis Inc. - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan heliusmedical.com HSDT|PASG: Multiplikator EV/Sales|Neuphoria - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NERV|ATHA: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCN (cyclerion.com)|Rasio nilai perusahaan marang dodolan Protagenic|KTTA: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan CRGT (cortigent.com)|ATXI: Multiplikator EV/Sales|BCLI (BrainStorm Cell Therapeutics) - Rasio nilai perusahaan marang pendapatan|CARA (Cara Therapeutics Inc.) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan CHRO|Nilai perusahaan marang pendapatan ELYM (Eliem Therapeutics)|Rasio nilai perusahaan marang pendapatan ITCI (Intra-Cellular Therapies Inc.)|Multiplikator EV/Sales LBPH (Longboard Pharma)|Multiplikator EV/Sales Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Multiplikator EV/Sales|Nilai bisnis marang pendapatan NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNPX|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE